Adam Laponis
Chief Financial OfficerMr. Adam Laponis is Chief Financial Officer of Twist Bioscience Corporation since January 8, 2024. He held a series of roles of increasing responsibility at Johnson & Johnson, where he led the divestiture of Cordis to Cardinal Health. He held additional positions within Johnson & Johnson including controller of the diabetes franchise, manager of supply chain and quality finance and customer service finance. He served as Chief Financial Officer at Eargo, Inc since June 2019 until January 5, 2024. From November 2018 to March 2019, Mr. Laponis served as Vice President of Financial Planning and Analysis for Tesla, Inc., an automotive and energy company, where he previously served as Senior Director of Finance from April 2017 to November 2018. Prior to that, he served as the Vice President and Chief Financial Officer of Cardiovascular Care of Cardinal Health, a healthcare services and products company, from October 2015 to April 2017. Prior to that, he served in various financial roles at Johnson & Johnson, a healthcare company, from August 2004 to October 2015. Mr. Laponis received a B.S. in chemical engineering from the University of California, Berkeley and his M.B.A. from the University of Southern California, Marshall School of Business.
Positions
- Company NameTwist Bioscience CorporationStock CodeTWSTPositionChief Financial OfficerColleagues
- EMEmily Marine LeproustCo-Founder, Board Chair & CEO
- PJPatrick John FinnPresident & COO
- DCDennis ChoChief Legal Officer & Corporate Secretary
- PGPaula GreenSenior Vice President of Human Resources
- RBRobert B. ChessLead Independent Director
- JJJan JohannessenIndependent Director
- MAMelissa A. StarovasnikIndependent Director
- KLKeith L. CrandellIndependent Director
